Doshi Mediventures Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 16-11-2024
- Paid Up Capital ₹ 0.28 M
as on 16-11-2024
- Company Age 18 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -3.70%
(FY 2023)
- Profit -11.58%
(FY 2023)
- Ebitda -2.76%
(FY 2023)
- Net Worth 24.51%
(FY 2023)
- Total Assets 4.06%
(FY 2023)
About Doshi Mediventures
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.28 M, as per Ministry of Corporate Affairs (MCA) records.
Mukesh Doshi, Hitesh Mukeshkumar, Yogesh Doshi, and Three other members serve as directors at the Company.
- CIN/LLPIN
U52209MH2006PTC159997
- Company No.
159997
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Feb 2006
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Doshi Mediventures?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hitesh Mukeshkumar  | Managing Director | 24-Feb-2006 | Current |
| Yogesh Doshi | Managing Director | 24-Feb-2006 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mukesh Doshi | Director | 24-Feb-2006 | Current |
| Surekha Doshi | Director | 28-Feb-2006 | Current |
| Hetal Doshi | Director | 28-Feb-2006 | Current |
| Maitri Doshi | Director | 28-Feb-2006 | Current |
Financial Performance of Doshi Mediventures.
Doshi Mediventures Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3.7% decrease. The company also saw a substantial fall in profitability, with a 11.58% decrease in profit. The company's net worth Soared by an impressive increase of 24.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Doshi Mediventures?
In 2023, Doshi Mediventures had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
N Chimanlal And Co Private LimitedActive 19 yearsMukesh Doshi, Hitesh Mukeshkumar and 1 more are mutual person
- Doshi Medicare Private LimitedActive 18 years 9 months
Mukesh Doshi, Hitesh Mukeshkumar and 4 more are mutual person
- General Drug Private LimitedActive 16 years 8 months
Mukesh Doshi, Hitesh Mukeshkumar and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Doshi Mediventures?
Unlock and access historical data on people associated with Doshi Mediventures, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Doshi Mediventures, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Doshi Mediventures's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
